-+ 0.00%
-+ 0.00%
-+ 0.00%

Yingpai Pharmaceutical (07630) officially joined the Hong Kong Stock Connect to open a channel for mainland investors to participate

Zhitongcaijing·09/04/2026 12:17:02
Listen to the news

The Zhitong Finance App learned that the Shanghai Stock Exchange issued a post-market notice on September 4. According to the relevant provisions of the “Shanghai Stock Exchange Shanghai-Hong Kong Stock Exchange Business Implementation Measures”, Yingpai Pharmaceutical (07630) officially transferred to the Hong Kong Stock Exchange's securities list. The adjustment will take effect on September 7 (Monday). This means that mainland investors can now directly trade Yingpai Pharmaceutical through the Shanghai-Shenzhen-Hong Kong Stock Connect, officially unlocking southbound capital.